BURKITT'S LYMPHOMA
Clinical trials for BURKITT'S LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new BURKITT'S LYMPHOMA trials appear
Sign up with your email to follow new studies for BURKITT'S LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cord blood transplant trial for blood cancers halted early
Disease control TerminatedThis study looked at using umbilical cord blood transplants after strong chemotherapy and radiation to treat various blood cancers like leukemia and lymphoma. It involved 200 participants and aimed to see how many were alive one year after transplant. The trial was stopped early,…
Matched conditions: BURKITT'S LYMPHOMA
Phase: NA • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Promising combo for tough blood cancers halted early — only 4 patients enrolled
Disease control TerminatedThis study tested whether adding rapamycin to high-dose chemotherapy could help people with aggressive blood cancers (like certain leukemias and lymphomas) that had returned or not responded to prior treatment. Only 4 adults aged 18–65 took part before the study was stopped early…
Matched conditions: BURKITT'S LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC